T1	disease_or_phenotypic_feature 60 65	tumor
T3	corrected_chemical 179 207	immune checkpoint inhibitors
T4	chemical 197 207	inhibitors
T5	chemical 413 416	NPC
T6	disease_or_phenotypic_feature 413 416	NPC
T7	disease_or_phenotypic_feature 565 571	injury
T8	corrected_chemical 604 626	dextran sulfate sodium
T10	disease_or_phenotypic_feature 635 642	colitis
T11	chemical 682 695	imidazolidine
T12	chemical 707 758	3-(2-chloro-6-fluorobenzyl)-imidazolidine-2,4-dione
T13	chemical 795 802	agonist
T14	disease_or_phenotypic_feature 912 925	schizophrenia
T15	chemical 1034 1043	glutamate
T16	disease_or_phenotypic_feature 1109 1112	HCl
T17	chemical 1114 1121	benzene
T18	chemical 1126 1133	toluene
T19	chemical 1231 1242	fidaxomicin
T20	disease_or_phenotypic_feature 1268 1271	CDI
T21	chemical 1319 1330	fidaxomicin
T22	chemical 1368 1379	fidaxomicin
T23	disease_or_phenotypic_feature 1423 1431	acquired
T24	disease_or_phenotypic_feature 1445 1453	disorder
T25	disease_or_phenotypic_feature 1577 1581	rare
T26	disease_or_phenotypic_feature 1600 1636	idiopathic intracranial hypertension
T27	disease_or_phenotypic_feature 1702 1709	disease
T28	disease_or_phenotypic_feature 1742 1778	idiopathic intracranial hypertension
T29	chemical 1802 1807	group
T30	chemical 1920 1925	group
T31	chemical 1952 1960	Adjuvant
T32	disease_or_phenotypic_feature 2095 2107	glioblastoma
T33	chemical 2223 2232	molecular
T34	disease_or_phenotypic_feature 2263 2273	infectious
T35	disease_or_phenotypic_feature 2274 2282	diseases
T36	chemical 2301 2311	Hemoglobin
T37	chemical 2317 2322	HbA1c
T38	disease_or_phenotypic_feature 2356 2368	hypoglycemia
T39	disease_or_phenotypic_feature 2373 2386	hyperglycemia
T40	chemical 2555 2564	phenolics
T41	disease_or_phenotypic_feature 2614 2623	condition
T42	chemical 2695 2698	RNA
T43	chemical 2711 2718	RNA-Seq
T44	disease_or_phenotypic_feature 2741 2761	colon adenocarcinoma
T45	disease_or_phenotypic_feature 2786 2792	Cancer
T46	chemical 2831 2850	L-cysteine/hydrogen
T47	chemical 2831 2858	L-cysteine/hydrogen sulfide
T48	disease_or_phenotypic_feature 2961 2981	erectile dysfunction
T49	chemical 3091 3094	DNA
T50	chemical 3096 3118	interferon-Î³-inducible
T51	chemical 3119 3126	protein
T52	chemical 3149 3156	GMP-AMP
T53	disease_or_phenotypic_feature 3188 3192	PRRs
T54	chemical 3249 3256	antigen
T55	chemical 3303 3310	antigen
T56	disease_or_phenotypic_feature 3314 3319	blood
T57	chemical 3342 3347	group
T58	disease_or_phenotypic_feature 3353 3361	diabetes
T59	chemical 3436 3455	palmitoyl-carnitine
T60	disease_or_phenotypic_feature 3477 3482	blood
T61	chemical 3483 3490	glucose
T62	chemical 3539 3548	oxidation
T63	chemical 3552 3560	pyruvate
T64	chemical 3816 3828	disinfection
T65	disease_or_phenotypic_feature 3830 3833	HLD
T66	corrected_disease_or_phenotypic_feature 3920 3939	metabolic disorders
T67	disease_or_phenotypic_feature 3930 3939	disorders
T68	disease_or_phenotypic_feature 3956 3963	obesity
T69	disease_or_phenotypic_feature 3965 3980	type 2 diabetes
T70	disease_or_phenotypic_feature 3993 4026	non-alcoholic fatty liver disease
T71	chemical 4007 4012	fatty
T72	chemical 4055 4062	glycine
T73	chemical 4179 4186	glycine
T74	disease_or_phenotypic_feature 4283 4286	ASD
T75	chemical 4302 4307	group
T76	chemical 4451 4456	group
T77	disease_or_phenotypic_feature 4470 4473	ASD
T78	chemical 4474 4479	group
R1	treats Arg1:T73 Arg2:T66
R2	treats Arg1:T3 Arg2:T1
R3	treats Arg1:T12 Arg2:T14
R6	causes_or_contributes_to Arg1:T8 Arg2:T10	
T2	corrected_disease_or_phenotypic_feature 548 571	small intestinal injury
T9	missed_chemical 534 539	NSAID
R7	causes_or_contributes_to Arg1:T9 Arg2:T2	
T79	missed_chemical 760 765	PT-31
R8	treats Arg1:T79 Arg2:T14	
